BSECompany Update3d ago · 22 Sept 2026, 04:49 pm
As attached
Eris Lifesciences Ltd · 540596
✦ AI SummaryFundraise
Eris Lifesciences Ltd has made an allotment of 1,55,264 equity shares under the ESOP-2021 scheme, increasing the company's paid-up share capital from ₹13,85,83,305 to ₹13,87,38,569.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Allotment
Attachments (1)
📄pdf
Download →
fbf75eba-cafa-442f-b7b8-7ad4cab5e84a.pdf
View document text
Date: 22September 2026
To To
BSE Limited National StockExchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza
Dalal Street Bandra Kurla Complex
Mumbai –400001 Bandra (E)
Mumbai –400051
SecurityCode: 540596 Symbol: ERIS
Dear Sir/Madam,
SUB: ALLOTMENT OFEQUITY SHARES PURSUANTTO ESOP-2021SCHEME
It is hereby informed that an allotment of 1,55,264 equity shares has been made on September 22, 2026,
pursuant toexercise of options under the ESOPScheme. Further details aretabulated below:
ESOP Scheme Year of Grant No. of equity shares allotted Issue priceper share
2022 66,422 Rs. 557.24/-
ESOP-2021 Scheme 2023 57,239 Rs. 510.32/-
2024 31,603 Rs. 728.16/-
The paid-up share capital of the Company accordingly stands increased from ₹13,85,83,305/- (13,85,83,305
equity shares of ₹1/- each) to ₹13,87,38,569 /- (13,87,38,569 equity shares of ₹1/- each).
The Informationmayplease betakenonrecords.
Thanking You,
For Eris Lifesciences Limited
MilindTalegaonkar
Company Secretary &ComplianceOfficer
ICSI Mem. No.:A26493